Author details

Full Name

Stephen F Garner

Affiliation

ORCID

Career Start Year

1987

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
31773757	The use of a hematology analyzer with a new generation of software as an alternative to flow cytometry for enumerating residual white blood cells in blood components.	Transfusion	2020
30742030	Flow cytometry for near-patient testing in premature neonates reveals variation in platelet function: a novel approach to guide platelet transfusion.	Pediatr Res	2019
28001309	Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time.	Vox Sang	2017
28487294	The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.	Blood	2017
28703137	Platelet function is modified by common sequence variation in megakaryocyte super enhancers.	Nat Commun	2017
27863252	The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.	Cell	2016
24627995	S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia.	British Journal of Clinical Pharmacology	2014
24308361	Expression of a single-chain human leukocyte antigen-DRA/DRB3*01:01 molecule and differential binding of a monoclonal antibody in the presence of specifically bound human platelet antigen-1a peptide.	Transfusion	2014
24477301	Immature platelet fraction analysis demonstrates a difference in thrombopoiesis between normotensive and preeclamptic pregnancies.	Thrombosis and Haemostasis	2014
23656729	Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.	Blood	2013
23222517	Seventy-five genetic loci influencing the human red blood cell.	Nature	2012
21738480	Multiple loci are associated with white blood cell phenotypes.	PLoS Genet	2011
20833976	Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function.	Blood	2010
19820697	A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium.	Nat Genet	2009
19221038	A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function.	Blood	2009
19429868	A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways.	Blood	2009
19109564	Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins.	Blood	2009
19459133	Single domain antibodies against the collagen signalling receptor glycoprotein VI are inhibitors of collagen induced thrombus formation.	Platelets	2009
19228925	A HaemAtlas: characterizing gene expression in differentiated human blood cells.	Blood	2009
19850043	PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways.	FEBS Lett	2009
18484951	A single-nucleotide polymorphism in the human ITGB3 gene is associated with the platelet-specific alloantigen Va (HPA-17bw) involved in fetal maternal alloimmune thrombocytopenia.	Transfusion	2008
18031296	Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies.	J Thromb Haemost	2008
18194381	Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.	Transfusion	2008
18065693	A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.	Blood	2008
17663743	Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus.	J Thromb Haemost	2007
17027020	Production of calmodulin-tagged proteins in Drosophila Schneider S2 cells: a novel system for antigen production and phage antibody isolation.	J Immunol Methods	2006
15813857	Teicoplanin-dependent antibodies: detection and characterization.	Br J Haematol	2005
14504096	Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody.	Blood	2004
15209903	Monoclonal antibody therapies in transfusion medicine.	Vox Sang	2004
14525779	Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR.	Blood	2004
12070047	Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia.	Blood	2002
11778077	Residual subset population analysis in WBC-reduced blood components using real-time PCR quantitation of specific mRNA.	Transfusion	2001
10607704	Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor.	Blood	2000
10691879	A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a.	Br J Haematol	2000
10218855	A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation.	Bone Marrow Transplant	1999
8604593	Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.	Acta Obstetricia et Gynecologica Scandinavica	1996
15387757	Do monocyte ADCC assays accurately predict the severity of hemolytic disease of the newborn caused by antibodies to high-frequency antigens?	Immunohematology	1996
9372121	Prenatal testing to predict the severity of hemolytic disease of the fetus and newborn.	Current Opinion in Hematology	1996
7625074	Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.	Vox Sanguinis	1995
7772544	Methods of measurement of Rh haemolytic disease.	British Journal of Haematology	1995
7841834	Monocyte isolation by flow cytometer-monitored centrifugal elutriation: a preparative tool for antibody-dependent cell-mediated cytotoxicity (ADCC) assays.	British Journal of Biomedical Science	1994
8484253	Severe immune haemolytic anaemia caused by intravenous immunoglobulin anti-D in the treatment of autoimmune thrombocytopenia.	Vox Sanguinis	1993
1413662	Severe haemolytic disease in an infant born to an Rh(null) proposita.	Vox Sanguinis	1992
1536816	Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.	British Journal of Haematology	1992
1807065	The importance of monitoring 'enzyme-only' red cell antibodies during pregnancy.	Vox Sanguinis	1991
1949717	A further example of anti-Di(b) not causing haemolytic disease of the newborn.	Vox Sanguinis	1991
2360237	Anti-Sc1 in pregnancy.	Transfusion	1990
3145543	ISBT monoclonal antibody workshop: report on group 3 (anti-Rh) antibodies.		1988
3127106	The use of macrophages stimulated by immune interferon as indicator cells in the mononuclear phagocyte assay.		1987
3038161	Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.	British Journal of Haematology	1987